BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ji J, Yang H. Using Probiotics as Supplementation for Helicobacter pylori Antibiotic Therapy.Int J Mol Sci. 2020;21. [PMID: 32046317 DOI: 10.3390/ijms21031136] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Bai X, Zhu M, He Y, Wang T, Tian D, Shu J. The impacts of probiotics in eradication therapy of Helicobacter pylori. Arch Microbiol 2022;204:692. [DOI: 10.1007/s00203-022-03314-w] [Reference Citation Analysis]
2 Liang B, Yuan Y, Peng X, Liu X, Hu X, Xing D. Current and future perspectives for Helicobacter pylori treatment and management: From antibiotics to probiotics. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.1042070] [Reference Citation Analysis]
3 Zhang J, Xie Q, Huo X, Liu Z, Da M, Yuan M, Zhao Y, Shen G. Impact of intestinal dysbiosis on breast cancer metastasis and progression. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1037831] [Reference Citation Analysis]
4 Wang Z, Wang F. Efficacy and safety comparison of Helicobacter pylori eradication between vonoprazan dual therapy versus triple therapy: a systematic review and meta-analysis. Therap Adv Gastroenterol 2022;15:17562848221125308. [PMID: 36268270 DOI: 10.1177/17562848221125308] [Reference Citation Analysis]
5 Santos FH, Panda SK, Ferreira DCM, Dey G, Molina G, Pelissari FM. Targeting infections and inflammation through micro and nano-nutraceuticals. Food Bioscience 2022;49:101891. [DOI: 10.1016/j.fbio.2022.101891] [Reference Citation Analysis]
6 Liu D, Wang J, Xie Y. Refractory Helicobacter pylori infection and the gastric microbiota. Front Cell Infect Microbiol 2022;12:976710. [DOI: 10.3389/fcimb.2022.976710] [Reference Citation Analysis]
7 Zeng J, Xie C, Zhang L, Liu X, Chan MTV, Wu WKK, Chen H. Host Cell Antimicrobial Responses against Helicobacter pylori Infection: From Biological Aspects to Therapeutic Strategies. Int J Mol Sci 2022;23:10941. [PMID: 36142852 DOI: 10.3390/ijms231810941] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Kumar R, Islam T, Nurunnabi M. Mucoadhesive carriers for oral drug delivery. J Control Release 2022:S0168-3659(22)00616-2. [PMID: 36116580 DOI: 10.1016/j.jconrel.2022.09.024] [Reference Citation Analysis]
9 Fakharian F, Asgari B, Nabavi-rad A, Sadeghi A, Soleimani N, Yadegar A, Zali MR. The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis. Front Cell Infect Microbiol 2022;12:953718. [DOI: 10.3389/fcimb.2022.953718] [Reference Citation Analysis]
10 Wu Y, Dong XY, Zhou XZ, Li ZS, Du YQ. Effects of probiotics on gastric microbiota and its precombination with quadruple regimen for Helicobacter pylori eradication. J Dig Dis 2022;23:462-72. [PMID: 36208049 DOI: 10.1111/1751-2980.13138] [Reference Citation Analysis]
11 Rodríguez-Pastén A, Pérez-Hernández N, Añorve-Morga J, Jiménez-Alvarado R, Cariño-Cortés R, Sosa-Lozada T, Fernández-Martínez E. The Activity of Prebiotics and Probiotics in Hepatogastrointestinal Disorders and Diseases Associated with Metabolic Syndrome. Int J Mol Sci 2022;23:7229. [PMID: 35806234 DOI: 10.3390/ijms23137229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Gościniak A, Eder P, Walkowiak J, Cielecka-piontek J. Artificial Gastrointestinal Models for Nutraceuticals Research—Achievements and Challenges: A Practical Review. Nutrients 2022;14:2560. [DOI: 10.3390/nu14132560] [Reference Citation Analysis]
13 Sheptulin AA, Rabotyagova YS. Нow to increase the effectiveness of eradication therapy of <i>Helicobacter pylori</i> infection? jour 2022;100:47-50. [DOI: 10.30629/0023-2149-2022-100-1-47-50] [Reference Citation Analysis]
14 Zhong MF, Li J, Liu XL, Gong P, Zhang XT. TCM-Based Therapy as a Rescue Therapy for Re-Eradication of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2022;2022:5626235. [PMID: 35251209 DOI: 10.1155/2022/5626235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Klang E, Soffer S, Barash Y, Shachar E, Lahat A. Changes in Helicobacter pylori Treatment from Discovery to Nowadays: A High-Level Analysis of PubMed Publications. CEG 2022;Volume 15:51-8. [DOI: 10.2147/ceg.s342048] [Reference Citation Analysis]
16 Han L, Shu X, Wang J. Helicobacter pylori-Mediated Oxidative Stress and Gastric Diseases: A Review. Front Microbiol 2022;13:811258. [PMID: 35211104 DOI: 10.3389/fmicb.2022.811258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
17 Mangiaterra S, Schmidt-küntzel A, Marker L, Di Cerbo A, Piccinini R, Guadagnini D, Turba ME, Berardi S, Galosi L, Preziuso S, Cerquetella M, Rossi G. Effect of a Probiotic Mixture in Captive Cheetahs (Acinonyx Jubatus) with Gastrointestinal Symptoms—A Pilot Study. Animals 2022;12:395. [DOI: 10.3390/ani12030395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Paucar-Carrión C, Espinoza-Monje M, Gutiérrez-Zamorano C, Sánchez-Alonzo K, Carvajal RI, Rogel-Castillo C, Sáez-Carrillo K, García-Cancino A. Incorporation of Limosilactobacillus fermentum UCO-979C with Anti-Helicobacter pylori and Immunomodulatory Activities in Various Ice Cream Bases. Foods 2022;11:333. [PMID: 35159484 DOI: 10.3390/foods11030333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Abukhader M, Ashouri Y, Yasir Al-ani S, Al-harthy N, Aljebouri A. Probiotics in medical sciences education: a survey-based study in Oman. International Journal of Health Promotion and Education. [DOI: 10.1080/14635240.2021.2022990] [Reference Citation Analysis]
20 Wang Y, Dong J, Wang J, Chi W, Zhou W, Tian Q, Hong Y, Zhou X, Ye H, Tian X, Hu R, Wong A. Assessing the drug resistance profiles of oral probiotic lozenges. J Oral Microbiol 2022;14:2019992. [PMID: 35024089 DOI: 10.1080/20002297.2021.2019992] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Das N, Ragavan ML, Mandal SK. Probiotics in the prevention and treatment of infections with Helicobacter pylori, Enterohemorrhagic Escherichia coli, and Rotavirus. Probiotics in the Prevention and Management of Human Diseases 2022. [DOI: 10.1016/b978-0-12-823733-5.00001-5] [Reference Citation Analysis]
22 Pogačar MŠ, Mičetić-turk D, Fijan S. Probiotics: current regulatory aspects of probiotics for use in different disease conditions. Probiotics in the Prevention and Management of Human Diseases 2022. [DOI: 10.1016/b978-0-12-823733-5.00021-0] [Reference Citation Analysis]
23 Lacerda DC, Trindade da Costa PC, Paulino do Nascimento LC, de Brito Alves JL. Probiotics for gastrointestinal health and disease treatment. Probiotics for Human Nutrition in Health and Disease 2022. [DOI: 10.1016/b978-0-323-89908-6.00022-4] [Reference Citation Analysis]
24 Ávila-alvarez KT, Chávez-gonzález ML, Segura-ceniceros EP, Martínez-hernández JL, Arredondo-valdes R, Govea-salas M, Nava-reyna E, Ilyina A, Ramos-gonzález R. Trends in the enzymatic inhibition by natural extracts. Value-Addition in Food Products and Processing Through Enzyme Technology 2022. [DOI: 10.1016/b978-0-323-89929-1.00030-5] [Reference Citation Analysis]
25 Ermolenko EI, Molostova AS, Gladyshev NS. Eradication therapy of helicobacteriosis with probiotics, problems, and prospects. jour 2021. [DOI: 10.31146/1682-8658-ecg-193-9-60-72] [Reference Citation Analysis]
26 Isayev HB, Ibrahimov MR, Salimov TH. Dependence of the state of the large intestine parietal microflora on the activity of Helicobacter pylori associated chronic gastritis. jour 2021;20:44-48. [DOI: 10.52420/2071-5943-2021-20-3-44-48] [Reference Citation Analysis]
27 Keikha M, Karbalaei M. Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections. BMC Gastroenterol 2021;21:388. [PMID: 34670526 DOI: 10.1186/s12876-021-01977-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
28 Sousa C, Ferreira R, Azevedo NF, Oleastro M, Azeredo J, Figueiredo C, Melo LDR. Helicobacter pylori infection: from standard to alternative treatment strategies. Crit Rev Microbiol 2021;:1-21. [PMID: 34569892 DOI: 10.1080/1040841X.2021.1975643] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
29 Gomez-Ramirez U, Valencia-Mayoral P, Mendoza-Elizalde S, Murillo-Eliosa JR, Solórzano Santos F, Contreras-Rodríguez A, Zúñiga G, Aguilar-Rodea P, Jiménez-Rojas VL, Vigueras Galindo JC, Salazar-García M, Velázquez-Guadarrama N. Role of Helicobacter pylori and Other Environmental Factors in the Development of Gastric Dysbiosis. Pathogens 2021;10:1203. [PMID: 34578235 DOI: 10.3390/pathogens10091203] [Reference Citation Analysis]
30 White B, Sterrett JD, Grigoryan Z, Lally L, Heinze JD, Alikhan H, Lowry CA, Perez LJ, DeSipio J, Phadtare S. Characterization of gut microbiome and metabolome in Helicobacter pylori patients in an underprivileged community in the United States. World J Gastroenterol 2021; 27(33): 5575-5594 [PMID: 34588753 DOI: 10.3748/wjg.v27.i33.5575] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
31 Saliba L, Zoumpopoulou G, Anastasiou R, Hassoun G, Karayiannis Y, Sgouras D, Tsakalidou E, Deiana P, Montanari L, Mangia NP. Probiotic and safety assessment of Lactobacillus strains isolated from Lebanese Baladi goat milk. International Dairy Journal 2021;120:105092. [DOI: 10.1016/j.idairyj.2021.105092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
32 He F, Wu X, Zhang Q, Li Y, Ye Y, Li P, Chen S, Peng Y, Hardeland R, Xia Y. Bacteriostatic Potential of Melatonin: Therapeutic Standing and Mechanistic Insights. Front Immunol 2021;12:683879. [PMID: 34135911 DOI: 10.3389/fimmu.2021.683879] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
33 Rudenko P, Vatnikov Y, Sachivkina N, Rudenko A, Kulikov E, Lutsay V, Notina E, Bykova I, Petrov A, Drukovskiy S, Olabode IR. Search for Promising Strains of Probiotic Microbiota Isolated from Different Biotopes of Healthy Cats for Use in the Control of Surgical Infections. Pathogens 2021;10:667. [PMID: 34071725 DOI: 10.3390/pathogens10060667] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
34 White BE, Sterrett JD, Grigoryan Z, Lally LT, Heinze JD, Alikhan H, Lowry CA, Perez L, Desipio J, Phadtare S. Characterization of gut microbiome and metabolome in Helicobacter pylori patients in an underprivileged community in the United States.. [DOI: 10.1101/2021.05.23.445270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Chen X, Zhou X, Liao B, Zhou Y, Cheng L, Ren B. The cross-kingdom interaction between Helicobacter pylori and Candida albicans. PLoS Pathog 2021;17:e1009515. [PMID: 33956895 DOI: 10.1371/journal.ppat.1009515] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
36 Park JM, Lee WH, Seo H, Oh JY, Lee DY, Kim SJ, Hahm KB. Microbiota changes with fermented kimchi contributed to either the amelioration or rejuvenation of Helicobacter pylori-associated chronic atrophic gastritis. J Clin Biochem Nutr 2021;69:98-110. [PMID: 34376919 DOI: 10.3164/jcbn.20-123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Lai WK, Lu YC, Hsieh CR, Wei CK, Tsai YH, Chang FR, Chan Y. Developing Lactic Acid Bacteria as an Oral Healthy Food. Life (Basel) 2021;11:268. [PMID: 33805077 DOI: 10.3390/life11040268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Ji J, Yang H. In Vitro Effects of Lactobacillus plantarum LN66 and Antibiotics Used Alone or in Combination on Helicobacter pylori Mature Biofilm. Microorganisms 2021;9:424. [PMID: 33670726 DOI: 10.3390/microorganisms9020424] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
39 Andreev DN, Kucheryavyy YA, Maev IV. Efficacy of butyric acid inclusion in eradication regimens for <i>Helicobacter pylori </i>infection: a meta-analysis of controlled trials. Terapevticheskii arkhiv 2021;93:158-163. [DOI: 10.26442/00403660.2021.02.200608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Savitha T, Sankaranarayanan A. Role of Probiotic Microbes Exerting Nutritional Properties. Advances in Probiotics 2021. [DOI: 10.1016/b978-0-12-822909-5.00011-3] [Reference Citation Analysis]
41 Roszczenko-Jasińska P, Wojtyś MI, Jagusztyn-Krynicka EK. Helicobacter pylori treatment in the post-antibiotics era-searching for new drug targets. Appl Microbiol Biotechnol 2020;104:9891-905. [PMID: 33052519 DOI: 10.1007/s00253-020-10945-w] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
42 Toh JWT, Wilson RB. Pathways of Gastric Carcinogenesis, Helicobacter pylori Virulence and Interactions with Antioxidant Systems, Vitamin C and Phytochemicals. Int J Mol Sci 2020;21:E6451. [PMID: 32899442 DOI: 10.3390/ijms21176451] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
43 Andreev DN, Maev IV, Samsonov AA. The importance of probiotics in optimizing the efficacy and safety of <i>Helicobacter pylori</i> infection eradication therapy. Medicinskij sovet 2020. [DOI: 10.21518/2079-701x-2020-5-9-16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]